Trial Search
Current Search Criteria:
Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01)
NASingle-patient trial aiming to provide immunological consolidation followin...
Status
Completed
Location
Ciusss-Emtl
Start Date
2024-01-16
Trial ID
NCT06391814
Treatments Being Tested
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation
PHASE1This Phase I dose-escalation trial is designed to evaluate the safety of ra...
Status
Active Not Recruiting
Location
Childrens National Medical Center
Start Date
2017-02-15
Trial ID
NCT03180216
Treatments Being Tested
CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL)
PHASE1The aim of this clinical trial is to evaluate the feasibility, safety and b...
Status
Terminated
Location
Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum
Start Date
2012-05
Trial ID
NCT01195480
Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies
PHASE2This is a Phase II trial to evaluate the efficacy and safety of human leuko...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2011-12
Trial ID
NCT01498484
Treatments Being Tested
Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.
NAThe goal of this prospective clinical study is to evaluate the safety and e...
Status
Recruiting
Location
The Catholic University of Korea Seoul St.Mary's Hospital
Start Date
2026-02-10
Trial ID
NCT07685457
Treatments Being Tested
Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT
NATo evaluate the efficacy and safety of donor EBV-specific T lymphocytes (EB...
Status
Unknown
Location
Zhao Wang
Start Date
2022-10-08
Trial ID
NCT05532826
Treatments Being Tested
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
PHASE1The purpose of this study is look at the safety of: * Taking a specific co...
Status
Terminated
Location
University of California, San Francisco
Start Date
2014-12-17
Trial ID
NCT02188719
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant
PHASE1This phase I/II trial studies the safety and toxicity of post-transplant tr...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2012-04
Trial ID
NCT01475058
Treatments Being Tested
Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies
PHASE1The purpose of this phase I/II trial is to study the side effects and best ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
1995-03
Trial ID
NCT00002663
Treatments Being Tested
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
PHASE1The primary purpose of this phase I/II study is to evaluate whether partial...
Status
Recruiting
Location
Jessie Alexander
Start Date
2025-04-30
Trial ID
NCT06909110